Regeneron Pharmaceuticals, Inc 10-K for FY2021
Regeneron Pharmaceuticals, Inc. (REGN)
10-K
2022-02-07
For: 2021-12-31
View Original
Added on
April 08, 2026
About this 10-K
Regeneron Pharmaceuticals, Inc filed this 10-K on February 7, 2022, covering the fiscal year ended December 31, 2021 (FY2021).
Headline figures
Fiscal year ended December 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $16.07B
- up 89.1% from $8.5B a year earlier
- Net income
- $8.08B
- up 129.9% from net income of $3.51B a year earlier
- Diluted EPS
- $71.97
- up 135.8% from $30.52 a year earlier